RADNOR, PA – (NewMediaWire) – December 28, 2024 – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) has informed investors that a securities class action lawsuit has been filed against Applied Therapeutics (NASDAQ:), (Applied Therapeutics) (NASDAQ: APLT) on behalf of those who have purchased or acquired Applied. Therapeutic securities between January 3, 2024 and December 2, 2024, inclusive (the Class Period). The lead plaintiff deadline is February 18, 2025.
Contact KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have experienced losses at Applied Therapeutics, you can click here or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=aplt&mktm= p
You can also contact Attorney Jonathan Nagy, Esq. By calling (484) 270-1453 or via email at info@ktmc.com.
Those accused of misconduct:
The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that Applied Therapeutics was not in compliance with the trial protocol and good clinical practices for its drug candidate, govorestat, which in turn created a risk A particularly severe form is the FDA's rejection of trial data in the context of a new drug application.
Lead Plaintiff Process:
Applied Therapeutics' investors may, no later than February 18, 2025, seek appointment as lead plaintiff representative for the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may elect to do nothing and remain an absent class member. A lead plaintiff is a representative party acting on behalf of all class members in directing the lawsuit. The lead plaintiff is usually the investor or a small group of investors who have the largest financial interest and who are also considered appropriate and typical of the proposed class of investors. The lead plaintiff selects an attorney to represent the lead plaintiff and the class and those attorneys, if approved by the court, are the lead attorneys or the class. Your ability to participate in any recovery is not affected by the decision of whether or not to serve as lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Applied Therapeutics investors who have incurred significant losses to contact the company directly for further information.
Click here to register for the case or go to: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=aplt&mktm=r
About Kessler Topaz Meltzer & Czech LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts across the country and around the world. The company has earned a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by corporations and credit institutions. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Czech LLP, please visit www.ktmc.com.
communication:
Kessler Topaz Meltzer & Czech, LLP
Jonathan Nagy, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, Pennsylvania 19087
info@ktmc.com
It may be considered an attorney's advertisement in some jurisdictions. Past results do not guarantee future results.
View the original version at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
